Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
142M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
47.8M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$568M
-
Value change
-
+$18.8M
-
Number of buys
-
45
-
Number of sells
-
-22
-
Price
-
$11.89
Significant Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) as of Q4 2021
92 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.8M shares
of 142M outstanding shares and own 33.7% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (8.93M shares), MPM ASSET MANAGEMENT LLC (4.95M shares), Logos Global Management LP (3.23M shares), Vida Ventures Advisors, LLC (2.96M shares), CITADEL ADVISORS LLC (2.86M shares), RA CAPITAL MANAGEMENT, L.P. (2.81M shares), BlackRock Inc. (2.41M shares), Deep Track Capital, LP (2.29M shares), WELLINGTON MANAGEMENT GROUP LLP (1.76M shares), and VANGUARD GROUP INC (1.39M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.